ITeos Therapeutics Inc

+1.64 (+9.68%)
Earnings Announcements

Iteos Reports Fourth Quarter And Full Year 2021 Results

Published: 03/23/2022 20:29 GMT
ITeos Therapeutics Inc (ITOS) - Iteos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Cash Balance of $848.5mm As of December 31, 2021, Providing Runway Into 2026.
Q4 Earnings per Share $4.88.
Q4 Earnings per Share View $1.28 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $85.56 Million
Adjusted EPS is expected to be $1.23

Next Quarter Revenue Guidance is expected to be $60.02 Million
Next Quarter EPS Guidance is expected to be $0.59

More details on our Analysts Page.